Bouthaina Dabaja, MD

Trials

Studies that name Bouthaina Dabaja, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:21 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07856758 · 2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute Lymphoblastic Leukemia Undergoing CAR T Cell Therapy

  M.D. Anderson Cancer Center · not yet recruiting · Acute Lymphoblastic Leukemia · principal investigator
• Ph2
  NCT05357794 · Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

  M.D. Anderson Cancer Center · recruiting · Mycosis Fungoides · principal investigator
• Ph2
  NCT02106988 · Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

  M.D. Anderson Cancer Center · active not recruiting · Lymphoma · principal investigator
• Ph1/Ph2
  NCT01321008 · Stage I/II Nasal NK Cell Lymphoma

  M.D. Anderson Cancer Center · terminated · Lymphoma · principal investigator
• Ph2
  NCT01073267 · Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides

  M.D. Anderson Cancer Center · completed · Lymphoma · study chair
• N/A
  NCT00925405 · Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy

  M.D. Anderson Cancer Center · terminated · Breast Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.